简介:
Overview
This article presents a protocol for isolating and characterizing CD4 + T-cell subsets from human peripheral blood. It emphasizes the use of flow cytometry to analyze the proportions of T-follicular helper cell subsets in different health states.
Key Study Components
Research Area
Background
- CD4 + T-cells play a crucial role in the adaptive immune response.
- T-follicular helper cells are vital for B-cell responses and antibody production.
Methods Used
- Flow cytometry for cell subset analysis
- Human peripheral blood as the biological system
- Batch processing technique for sample analysis
Main Results
- Identification of differences in T-follicular helper cell subsets between healthy and diseased individuals.
- Proven correlation of T-follicular helper cell subsets with clinical disease markers.
- Verification of method efficacy and practicality in clinical settings.
Conclusions
- This study demonstrates a reliable method for evaluating T-follicular helper subsets in various health statuses.
- The findings are significant for understanding disease progression and potential biomarkers.
What are CD4 + T-cells?
CD4 + T-cells are a type of white blood cell that plays an essential role in the immune system, particularly in helping other cells respond to infections.
How does flow cytometry work?
Flow cytometry is a technology used to analyze the physical and chemical characteristics of cells or particles as they flow in a fluid stream.
Why are T-follicular helper cells important?
T-follicular helper cells assist in the activation of B-cells and the production of antibodies, which are critical for immune defense.
Can this method be used in clinical settings?
Yes, the protocol developed in this study is practical for use in clinical laboratories for assessing disease states.
What advantages does this technique offer?
The method is fast, allows batch processing of samples, and maintains cell viability for further analyses.
How are the results of T-follicular helper subsets utilized?
Results can be used as biomarkers for disease progression and severity in patients.
Who contributed to this research?
Dr. Lucia Pi has contributed significantly to demonstrating this procedure.